h. 6B in kids), even though being disadvantageous inside an additional. The net effectiveness will probably be improved upon only if the additional serotype has a larger case-to-carrier proportion compared to the#links# common case-to-carrier proportion of the current non-vaccine sorts as well as the degree of advancement inside success is dependent upon the particular buggy incidence with the ser